Thursday, Abbott Laboratories (NYSE:ABT) said it is recalling some FreeStyle Libre 3 sensors after finding ... Continuous ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

In June, Abbott Laboratories announced that the U.S. Food and Drug Administration (FDA) had cleared the Libre Rio, a new over-the-counter (OTC) CGM option for type 2 diabetes patients who do not ...

MedTech is a promising market driven by rising disease prevalence, innovative healthcare solutions, and significant growth in ...

Abbott Laboratories is best known for its medical ... franchise, the FreeStyle Libre. It has been its best-performing device for years, but as Abbott reported earlier this year, only 1% of the ...

Abbott Laboratories, Inc. ABT recently announced ... the global heart pump device market was valued at $2.2 billion in 2023 and is expected to witness a CAGR of 17.4% by 2032.

DexCom markets one of the world's most popular constant blood glucose monitors (CGM). These discreet devices adhere to the ...

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...

Thursday, Abbott Laboratories (NYSE:ABT) said it is recalling some FreeStyle Libre 3 sensors after finding that a small ... Dexcom’s Stelo Device Brings Affordable Continuous Glucose Monitoring To ...